Cancer immunotherapy has been hailed as the most promising advancement for the treatment of cancer. Gain insights into market-leading content from our internal experts and learn more about the recent developments in cancer research, in particular, the new and emerging therapies built on immuno-oncology.
Amy Braden - Solutions Specialist
Dr. Richard Harrison - Chief Scientific Officer
Di Cross - Director of Research Analytics
Imagine you could collaborate and share data easily with your âdream teamâ of clinical scientists, all focused on the same problem.
The Childrenâs Tumor Foundationâs data sharing platform enables you to do just this. Watch our webinar to learn how from CTFâs experts. You will also hear about the CTFâs open-access platform, which shares findings and results with the research community, and the techniques they have utilized for target selection and finding the right research partners to collaborate with.View our webinar
Immuno-oncology Innovation Toolkit:
Groundbreaking work is emerging in the field of immuno-oncology. Clarivate Analytics provides easy access to comprehensive and market-leading information, tools, and expertise needed to make the critical decisions that drive immuno-oncology drug discovery.
Thought Leadership Reports:
Read expert analysis of the academic, patent, and life sciences immuno-oncology landscape.
Cancer InnovationVU Tool:
Use the Cancer InnovationVU tool to interact with data and explore the relationships between cancer incidence/mortality, intellectual property, and research funding.